This company listing is no longer active
Thermo Fisher Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Thermo Fisher Scientific has a total shareholder equity of $47.5B and total debt of $35.2B, which brings its debt-to-equity ratio to 74.1%. Its total assets and total liabilities are $98.5B and $51.0B respectively. Thermo Fisher Scientific's EBIT is $7.5B making its interest coverage ratio 22.6. It has cash and short-term investments of $8.8B.
Key information
74.1%
Debt to equity ratio
US$35.22b
Debt
Interest coverage ratio | 22.6x |
Cash | US$8.82b |
Equity | US$47.54b |
Total liabilities | US$50.96b |
Total assets | US$98.50b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TN8's short term assets ($25.5B) exceed its short term liabilities ($14.8B).
Long Term Liabilities: TN8's short term assets ($25.5B) do not cover its long term liabilities ($36.2B).
Debt to Equity History and Analysis
Debt Level: TN8's net debt to equity ratio (55.5%) is considered high.
Reducing Debt: TN8's debt to equity ratio has increased from 66.4% to 74.1% over the past 5 years.
Debt Coverage: TN8's debt is well covered by operating cash flow (26.5%).
Interest Coverage: TN8's interest payments on its debt are well covered by EBIT (22.6x coverage).